Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology October 14, 2021 Auto Bot News 0 The collaboration between Intellia and SparingVision will work to develop genomic medicines for ocular diseases.
